Invenomic Capital Management Reduces ConocoPhillips Stake

Institutional investor sells 10,918 shares of energy producer's stock

Mar. 16, 2026 at 12:20pm

Invenomic Capital Management LP decreased its position in ConocoPhillips (NYSE:COP) by 6.6% during the third quarter, according to a recent SEC filing. The institutional investor now owns 154,135 shares of the energy producer's stock, valued at $14,580,000.

Why it matters

This filing provides insight into the investment decisions of Invenomic Capital Management, a notable institutional investor in the energy sector. Changes in major shareholders' positions can signal shifts in market sentiment or portfolio strategy.

The details

Invenomic Capital Management sold 10,918 shares of ConocoPhillips stock during the third quarter. The firm now owns 154,135 shares, down from 165,053 shares held previously. ConocoPhillips is an independent exploration and production company focused on crude oil, natural gas and natural gas liquids.

  • Invenomic Capital Management filed the 13F report for the third quarter of 2026.

The players

Invenomic Capital Management LP

An institutional investment firm that manages a portfolio focused on the energy sector.

ConocoPhillips

A major independent oil and gas exploration and production company headquartered in Houston, Texas.

Got photos? Submit your photos here. ›

The takeaway

This filing indicates that Invenomic Capital Management has reduced its exposure to ConocoPhillips, potentially signaling a shift in the firm's energy sector investment strategy or a broader market view. However, without additional context, it's difficult to draw firm conclusions about the motivations behind the portfolio adjustment.